Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04605029
Other study ID # FORECAST
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 1, 2017
Est. completion date December 31, 2019

Study information

Verified date October 2020
Source Queen's University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This pilot study will study the impact of critical illness and ICU processes of care on the trajectory and development of frailty. It is hypothesize that frailty in survivors of critical illness will be measurable at hospital discharge, will correlate with processes of care while in ICU and will better discriminate long term outcomes when compared to severity of illness or the degree of frailty present on ICU admission. This pilot study will be conducted in a tertiary medical surgical ICU at Kingston General Hospital- Kingston, Ontario. It will inform the feasibility, timelines and sample size for the multi-center study and will allow for the refinement of study procedures and data collection methods. This study will be published separately as a stand-alone pilot.


Description:

Single Center Observational pilot study to inform on the conduct of a multi-center observational study.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date December 31, 2019
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 55 Years and older
Eligibility Inclusion Criteria: 1. Age > 55 years 2. Admission to ICU for over 24 hours 3. Receipt of at least one therapeutic life support intervention that can only be delivered in the ICU such as mechanical ventilation (both invasive and non-invasive), vasoactive medications (vasopressors or inotropes) or acute renal replacement therapy. Exclusion Criteria: 1. Lack of consent for study inclusion or lack of consent to be contacted for long term follow-up. 2. Expected to survive for less than 72 hours after ICU admission. 3. Inability to obtain baseline blood work less than 48 hours after ICU admission (i.e. study enrollment must occur within 48 hours of ICU admission allowing for the blood work to be done in the time allowed). 4. No family or caregivers available to collect collateral history. 5. Not able to speak English with lack of available medical translators. 6. Admission to ICU with acute structural neurological disease: 1. Massive stroke requiring ICU care 2. Spinal cord injury with neurological deficit

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Canada Kingston Health Sciences Centre Kingston Ontario

Sponsors (2)

Lead Sponsor Collaborator
Dr. John Muscedere Canadian Frailty Network

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients with a measure of frailty prior to hospital discharge. Measure of the Frailty Index and Clinical Frailty Scale prior to discharge 6 months
Primary Correlation of frailty severity at hospital discharge with long term outcomes (mortality, Quality of Life and Need for Institutionalization) Clinical outcomes at 6 months will include mortality, Quality of Life (EQ5L) and need for Institutionalization 6 months
Primary Impact of admission critical illness on the development and severity of frailty as measured by a Frailty Index or Clinical Frailty Scale Correlation with the progression or presence of frailty as measured with the Frailty Index or Clinical Frailty Scale 28 days and at 6 months
Primary Correlation of ICU processes of care (nutritional adequacy, mobilization and sedation) with frailty progression as measured by the Clinical Frailty Scale or Frailty Index Correlation of processes of care in ICU (nutritional adequacy, mobilization and sedation) with frailty progression 28 days
See also
  Status Clinical Trial Phase
Completed NCT04551508 - Delirium Screening 3 Methods Study
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT03671447 - Enhanced Recovery After Intensive Care (ERIC) N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT04674657 - Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
Completed NCT04239209 - Effect of Intensivist Communication on Surrogate Prognosis Interpretation N/A
Completed NCT05531305 - Longitudinal Changes in Muscle Mass After Intensive Care N/A
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Completed NCT02916004 - The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients. N/A
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04479254 - The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study) N/A
Recruiting NCT04475666 - Replacing Protein Via Enteral Nutrition in Critically Ill Patients N/A
Not yet recruiting NCT04516395 - Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae N/A
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Withdrawn NCT04043091 - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction N/A
Recruiting NCT02922998 - CD64 and Antibiotics in Human Sepsis N/A
Recruiting NCT02989051 - Fluid Restriction Keeps Children Dry Phase 2/Phase 3
Completed NCT02899208 - Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients? N/A
Completed NCT03048487 - Protein Consumption in Critically Ill Patients
Recruiting NCT02163109 - Oxygen Consumption in Critical Illness